Last reviewed · How we verify
IDP-123 Vehicle Lotion
IDP-123 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients through the skin for localized or systemic therapeutic effect.
IDP-123 is a topical lotion vehicle formulation designed to deliver active pharmaceutical ingredients through the skin for localized or systemic therapeutic effect. Used for Vehicle formulation for topical dermatological applications (specific indication dependent on active ingredient).
At a glance
| Generic name | IDP-123 Vehicle Lotion |
|---|---|
| Also known as | Vehicle |
| Sponsor | Bausch Health Americas, Inc. |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 3 |
Mechanism of action
IDP-123 Vehicle Lotion is a pharmaceutical delivery system (excipient/vehicle formulation) rather than an active drug itself. It is engineered to enhance percutaneous absorption and bioavailability of incorporated active ingredients through optimized emulsion chemistry and skin penetration enhancement. The vehicle formulation facilitates consistent drug delivery across the stratum corneum and viable epidermis.
Approved indications
- Vehicle formulation for topical dermatological applications (specific indication dependent on active ingredient)
Common side effects
- Application site irritation
- Application site erythema
Key clinical trials
- A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (301) (PHASE3)
- A Phase 3, Vehicle-controlled Efficacy and Safety Study of IDP-123 Lotion in the Treatment of Acne Vulgaris (302) (PHASE3)
- Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris (PHASE2)
- Study to Compare the Safety and Efficacy of IDP-123 Lotion to Tazorac Cream in the Treatment of Acne Vulgaris (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IDP-123 Vehicle Lotion CI brief — competitive landscape report
- IDP-123 Vehicle Lotion updates RSS · CI watch RSS
- Bausch Health Americas, Inc. portfolio CI